Navigation Links
Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement
Date:5/12/2008

ditional capacity in preparation of the potential launch of its investigational anti-platelet agent.

Howard Solomon, Chairman and CEO of Forest, commented: "We have enjoyed a very fruitful partnership with Daiichi Sankyo since our initial collaboration of Benicar which began in 2002. Our decision to reallocate resources to our currently marketed products causes us to forego the opportunity to continue to participate in the promotion of Daiichi Sankyo's excellent product AZOR."

Solomon continued, "However, Daiichi Sankyo and Forest's partnership will continue for another six years during which Forest will have a residual participation in Benicar and Benicar HCT profits, but will not be actively promoting those products. The result of terminating Forest's active promotion of both Benicar and AZOR will make available to Forest the equivalent of an additional 500-person sales force which Forest requires for the support of its proprietary products. We greatly admire Daiichi Sankyo, and we have both benefited from its creative product development, skillful marketing, and the highest standards of ethical partnership."

Daiichi Sankyo President and CEO Joseph P. Pieroni said, "Our first co-promotion agreement with Forest provided us with important additional resources to build our franchise of Benicar and Benicar HCT into significant products in the antihypertensive market while we built our own sales force. Our second co-promotion collaboration for AZOR allowed us to quickly and comprehensively educate the medical community about this new combination antihypertensive. Now we can take over full responsibility for the continued success of these brands."

AZOR was approved by the US Food and Drug Administration September 26, 2007. Forest will continue to co-promote AZOR until June 30, 2008. Health care providers with questions regarding AZOR or any Daiichi Sankyo product should call Daiichi Sankyo at 877 4DSPROD (437-7763).

About Forest Labora
'/>"/>

SOURCE Forest Laboratories, Inc.; Daiichi Sankyo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement
2. Forest Laboratories, Inc. Announces Positive Results of Memantine Study of Once-Daily Formulation
3. Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Additional Lawsuit Against Several Companies for Patent Infringement
4. Forest and Cypress Announce Submission of New Drug Application for Milnacipran for the Treatment of Fibromyalgia Syndrome
5. BioSpace Launches 3rd Edition of BioForest(TM) Bioscience Marketing Campaign
6. Drugs from Johnson & Johnson/Basilea and Forest Are the Most Promising Antibiotics in the Community-Acquired Pneumonia Pipeline
7. Nanotube forests grown on silicon chips for future computers, electronics
8. Forest Laboratories Lexapro and Generics-Dominated Fluoxetine Lead First-Line Therapy in the Treatment for Major Depression
9. Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
10. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
11. Clontech Laboratories, Inc. Releases the ProteoTuner(TM) Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... MA (PRWEB) July 30, 2014 ... (UC) and collaboration company, is proud to announce ... account management positions in their Boston, Charleston and ... response to the increased demand for hosted solutions, ... operational efficiency and reduce cost. , SoundConnect was ...
(Date:7/29/2014)... The advanced optical methods and applications for ... a revolution in the neurosciences were the inspiration behind ... SPIE, the international society for optics and photonics ... of the BRAIN Initiative in the United States, and ... vision for and provide examples of the impact that ...
(Date:7/29/2014)... Cheshire Cat: Can a particle be separated from its ... Communications , published the results of the first Cheshire ... conducted by Chapman University in Orange, CA, and Vienna ... a cat without a grin," thought Alice in Wonderland, ... curious thing I ever saw in my life!" Alice,s ...
(Date:7/29/2014)... 29, 2014  The Society for Clinical Research ... program for the 9 th annual Site ... Amelia Island , Florida.  The focus on ... unchanged, however, the topics and format will allow ... among all stakeholders with a continued focus on ...
Breaking Biology Technology:SoundConnect Organization and Culture is Evolving 2SPIE Launches 'Neurophotonics' Journal with Special Section on BRAIN Initiative 2SPIE Launches 'Neurophotonics' Journal with Special Section on BRAIN Initiative 3SPIE Launches 'Neurophotonics' Journal with Special Section on BRAIN Initiative 4The quantum Cheshire cat: Scientists separate a particle from its properties 2The quantum Cheshire cat: Scientists separate a particle from its properties 3The quantum Cheshire cat: Scientists separate a particle from its properties 4TransCelerate, Lilly, Pfizer, and FDA Highlight Collaborative Program at the Site Solutions Summit 2TransCelerate, Lilly, Pfizer, and FDA Highlight Collaborative Program at the Site Solutions Summit 3
... prescription ... solution, ... new Xtremityscan System and give away a free unit at the ... Xtremityscan is a digital shape acquisition system that allows users ...
... to Create One of the Industry,s Largest eClinical ... ... PAREXEL International,Corporation (Nasdaq: PRXL ), a leading global biopharmaceutical ... plc, a company traded on the London Stock Exchange, ("ClinPhone"),have ...
... June 13 On Thursday, June 19, 2008,at 7:00 ... Time,members of Cell Therapeutics, Inc.,s (CTI) (Nasdaq and MTA: ... of the Annual Meeting,of Shareholders at its Seattle headquarters ... meeting will be webcast live on CTI,s website,at ...
Cached Biology Technology:PAL Health Technologies Debuts Xtremityscan System at Western Podiatric Medical Congress 2PAREXEL Reaches Agreement To Acquire ClinPhone 2PAREXEL Reaches Agreement To Acquire ClinPhone 3PAREXEL Reaches Agreement To Acquire ClinPhone 4PAREXEL Reaches Agreement To Acquire ClinPhone 5Cell Therapeutics, Inc. Special Meeting in Lieu of Annual Meeting of Shareholders Scheduled for Thursday, June 19, 2008 2
(Date:7/30/2014)... the first high-resolution map of the carbon stocks ... Per. The new and improved methodology used to ... future market-based carbon economies. The new carbon ... and it provides the critical input to studies ... use, and enforcement purposes. The technique includes the ...
(Date:7/30/2014)... in the journal Scientific Reports , published by ... Ganguly found that while global temperature is indeed increasing, ... instance, while each year,s average hottest and coldest temperatures ... fall within a wider range of potential high and ... means that even as overall temperatures rise, we may ...
(Date:7/29/2014)... by academics in the University of Bristol,s Nutrition and ... liquid calories into account when planning meals. , The ... Study of Ingestive Behavior Conference (SSIB 2014) in Seattle, ... that we do. , The team was led by ... of Experimental Psychology. , As part of a Biotechnology ...
Breaking Biology News(10 mins):Peru's carbon quantified: Economic and conservation boon 2Peru's carbon quantified: Economic and conservation boon 3Big data confirms climate extremes are here to stay 2
... Fusarium samples. A Virginia Tech plant pathologist ... detect airborne pathogens above agricultural fields. , ... and weed science in the College of Agriculture ... and engineering with his interdisciplinary research but has ...
... common practice among many college students involves "pulling all-nighters", ... practice associated with lower grade-point averages compared to those ... abstract that will be presented Wednesday at SLEEP 2007, ... Societies (APSS). , "Sleep in college students is generally ...
... a microbial protein to improve water quality. , But ... from potentially toxic nanoparticles in their own environments, and ... the same thing on a larger scale. , ... and Lawrence Berkeley National Laboratory found that bacteria from ...
Cached Biology News:Small, self-controlled planes combine plant pathology and engineering 2Small, self-controlled planes combine plant pathology and engineering 3Microbes at work cleaning up the environment 2
Request Info...
... EC135-90 is a compact, highly versatile power supply. ... 500 milliamps, this power supply is ideal for ... well as all types of small format transfer ... voltage or constant current with a continuously variable ...
... The BV-10 offers precision beveling ... and 50m. The unique abrasive ... free for greater control of ... be accomplished very rapidly and ...
Human interferon-beta (IFN-beta). Recognizes amino acids 30-47 of IFN-beta. No cross-reactivity with Human IFN-alpha or IFN-gamma....
Biology Products: